Media

Event
Medical
Corporate
Medical
2019-11-06

cancer genomic profiling empowers gynecologic oncologists to fight against late-stage ovarian caner

Choosing appropriate cancer drugs via comprehensive cancer genomic profiling can help young ovarian cancer patients to survive longer and preserve fertility.

Published:

Taipei

Author(s):

Health News

Medical
2019-09-09

Immunotherapy empower an 87- year- old patient to defeat skin cancer relapse

An 87-year-old patient suffered from skin cancer relapse , ACTOnco+ helped her understood cancer genetic mutations and she was lucky to be the 20% who can benefit from immunotherapy

Published:

Yun-lin

Author(s):

Health News

Medical
2019-08-08

NGS multi-gene testing provide lung cancer patients better treatment opportunities

Cancer precision medicine is spread among different hospitals, beside current treatment procedures, patients with difficult to treat cancer can seize the opportunity at first time and ensure the right for drug selection, increase success rate and find be

Published:

Taipei

Author(s):

Health News

Corporate
2019-07-26

ACT Genomics is The Winner of 2019 Taipei Biotechnology Award and Mayor of Taipei Said Biotechnology is The Most Promising Industry

ACT Genomics is the winner of "2019 Taipei Biotechnology Award" with 1 million grants from Taipei City Government. Dr. Ko Wen-Je, Mayor of Taipei expressed that the next promising industry is biotechnology, and the cluster is formed in Taipei city.

Published:

Taipei

Author(s):

Medical
2019-07-18

Breakthrough in immunotherapy with TMB evaluation from FFPE

New immunotherapy and targeted therapy are rising and FFPE can help to get comprehensive genomic information

Published:

Taipei

Author(s):

Corporate
2019-07-18

ACT Genomics Wins Taiwan Bio Industry Organization Awards- Emerging Company of the Year

ACT Genomics drives innovation in global standard and individual markets, winning Taiwan Bio Industry Organization Awards- Emerging Company of the Year.

Published:

Taipei

Author(s):

Medical
2019-06-11

New Targeted Therapy for Ovarian Cancer Requiring DNA Repair Genes Testing

Through DNA Repair Genes Testing, patients can accept new targeted therapy-PARP inhibitor for high quality and more relaxed treatment process, and maximize the utility of medical expenses.

Published:

Taipei

Author(s):

Health News

Medical
2019-05-10

Fight Cancer With NGS !Authority in Lung Cancer Use CGP To Defeat Cancer

Chun-Ming Tsai, Consultant Physician Taipei Veterans General Hospital cooperates with ACT Genomics to use ACTDrug+ & ACTMonitor to assist 202 patients to fight cancer successfully

Published:

Taipei

Author(s):

Health News

Corporate
2019-04-19

ACT Genomics Establishes NGS Laboratory to Offer Comprehensive Cancer Genomic Profiling Service in Japan

More precision cancer medicine are available for clinical needs and drug development in Japan! Find out more at the new analysis laboratory "Shonan iPark Laboratory" of ACTmed, a joint venture between Canon Medical Systems and ACT Genomics in Japan.

Published:

Taipei

Author(s):

PRWire

Corporate
2018-12-06

ACT Genomics joins TMB Harmonization Project

TMB (tumor mutational burden) is an important biomarker for predicting immunotherapy response. The project convened major diagnostics company to standardize TMB calculation across tests. ACT Genomics is the only non-US company participating in the project

Published:

Author(s):